. Enhanced baroreflex-mediated inhibition of respiration after muscimol dialysis in the rostroventral medulla. J Appl Physiol 92: 2554-2564, 2002. First published February 8, 2002 10.1152/japplphysiol.00895.2001The rostral ventral medulla (RVM) may be important in the control of cardiorespiratory interactions. We hypothesized that inhibition of the RVM would enhance inhibition of breathing associated with transient blood pressure elevations. In 25 piglets 3-16 days of age, we studied the effect of acutely increasing blood pressure, by systemic infusion of phenylephrine, on respiratory activity before and after inhibition of neural activity in the RVM by dialysis of 10 mM muscimol, a GABAA-receptor agonist. Muscimol dialysis through probes that were placed along the ventral medullary surface from ϳ1 mm rostral to the facial nucleus to ϳ0.5 mm caudal to the facial nucleus augmented the respiratory inhibition associated with acute increases in blood pressure. No similar enhancement of respiratory inhibition after phenylephrine treatment was seen in six control animals that did not receive muscimol dialysis. We conclude that the piglet RVM participates in cardiorespiratory interactions and that dysfunction of homologous regions in the human infant could lead to cardiorespiratory instability and may be involved in the pathogenesis of sudden infant death syndrome. phrenic nerve; sudden infant death syndrome; parapyramidal nucleus; caudal raphé; retrotrapezoid nucleus; nucleus paragigantocellularis lateralis THE SUDDEN INFANT DEATH SYNDROME (SIDS) is the most common cause of death in infants Ͻ1 yr of age in the developed world. In the United States, the present rate of SIDS is ϳ0.8 deaths per 1,000 births. The most widely accepted putative cause of SIDS is failure of respiratory or cardiovascular control during sleep. However, the mechanisms or triggers for such catastrophic failure are unclear. Recently, specific developmental abnormalities have been described in the ventral medulla of SIDS victims (12, 19, 22, 27, 28) . These ventral medullary structures in the infant may be homologous with chemosensitive areas of the medulla in animals responsible for respiratory and cardiovascular control (11).
THE SUDDEN INFANT DEATH SYNDROME (SIDS) is the most common cause of death in infants Ͻ1 yr of age in the developed world. In the United States, the present rate of SIDS is ϳ0.8 deaths per 1,000 births. The most widely accepted putative cause of SIDS is failure of respiratory or cardiovascular control during sleep. However, the mechanisms or triggers for such catastrophic failure are unclear. Recently, specific developmental abnormalities have been described in the ventral medulla of SIDS victims (12, 19, 22, 27, 28) . These ventral medullary structures in the infant may be homologous with chemosensitive areas of the medulla in animals responsible for respiratory and cardiovascular control (11) .
Control of the cardiovascular and respiratory systems is closely linked, both anatomically and physiologically. Acute increases in blood pressure inhibit breathing (2, 9, 29, 33) , probably via carotid and aortic baroreceptor stimulation (9) . However, the regions of the central nervous system (CNS) mediating cardiorespiratory interactions are not fully established. The ventral medulla contains areas involved in the control of cardiovascular and respiratory output. Some studies suggest that the rostroventrolateral medulla (RVLM), which contains the C1 region, may be the site of cardiorespiratory interactions (4, 8, 15) . The pattern of activation of the RVLM may depend in turn on activity of the caudal ventrolateral medulla (CVLM) (31) . We have been studying the effect of inhibition of a more rostral region of the ventral medulla, the rostroventral medulla (RVM), on ventilation and sleep (5-7). Inhibition of this region reduces the ventilatory response to CO 2 (5, 6, 25) and hypoxia (25) and may reduce the ventilatory output during wakefulness (24) and sleep (26) . We defined the RVM as a region within 1.2 mm of the ventral surface that extends rostocaudally the length of the facial nucleus and mediolaterally ϳ1.5-4.0 mm from the midline. This area encompasses the retrotrapezoid nucleus, the parapyramidal region, and juxtafacial parts of the nucleus paragigantocellularis lateralis (6) . The RVM is, therefore, distinct from and rostral to the RVLM (the rostral extent of the RVLM is usually the caudal end of the facial nucleus). However, the caudal RVM does abut, and may overlap slightly, the rostral RVLM.
In the present study, we examined the effect of inhibition of the RVM on interactions between the respiratory and cardiovascular systems. We were particularly interested in the possibility that defects within the RVM may promote cardiorespiratory instability and contribute to the pathogenesis of SIDS. Therefore, we conducted our analysis of cardiorespiratory interactions in neonatal piglets. We subjected these animals to elevations in systemic blood pressure, which inhibits respiratory activity, before and after muscimol dialysis in the RVM. It was our hypothesis that elevating systemic blood pressure would more effectively inhibit respiration after dialysis of muscimol in the RVM.
METHODS
Successful experiments were performed on a total of 31 piglets (3-16 days of age, 2.1-5.8 kg body wt). Piglets were housed with the sow in our on-site animal care facility. The Institutional Animal Care and Use Committee of Dartmouth College approved all protocols.
Surgery. Animals were anesthetized with 2% halothane (2-bromo-2-chloro-1,1,1-trifluoroethane; Halocarbon Laboratories) in O2. Body temperature was monitored with a rectal probe and maintained at 38-39°C using a heating pad and radiant heat source. Femoral arterial and venous catheters were inserted for measurement of blood pressure and administration of drugs, respectively. Piglets were tracheostomized and artificially ventilated (Dual-Phase Respirator, Harvard Apparatus, S. Natick, MA). The carotid sinus regions were exposed bilaterally, and the internal and external carotid arteries were ligated to facilitate decerebration. Care was taken to avoid damaging the carotid sinus nerves. The vagus nerves were sectioned bilaterally in the neck to prevent entrainment of the respiratory activity of each animal to the ventilator. Each piglet was placed prone with its head positioned in a stereotaxic apparatus (Kopf Instruments, Tujunga, CA). After the skull was opened, each animal was decerebrated at the level of the superior colliculus. Anesthesia was discontinued after decerebration, and animals were paralyzed with pancuronium bromide (1 mg/kg iv; ElkinsSinn, Cherry Hill, NJ). Supplemental doses of pancuronium bromide were given as required, usually at a rate of 0.5 mg ⅐ kg Ϫ1 ⅐ h Ϫ1 . The phrenic nerve was exposed in the neck, and a branch of the nerve was placed on bipolar recording electrodes to monitor respiratory output. Peak integrated phrenic nerve activity, body temperature, end-tidal PCO2 and PO2, and blood pressure were recorded on a computer-based data acquisition system (PowerLab, ADI, Castle Hill, Australia) for later analysis.
A dialysis probe was placed in the left side of the RVM using stereotaxic coordinates developed previously (30) . We defined the RVM as the region ventral and ventromedial to the facial nucleus extending rostrocaudally from the caudal end of the rostral chemosensitive area (Mitchell's area) to the rostral part of the intermediate area (Schlaefke's area) (5) . A microdialysis guide tube was inserted through the dorsal surface of the brain stem to within 1-1.5 mm from the ventral medullary surface at the level of the facial nucleus. A microdialysis probe (BAS, West Lafayette, IN) with a dialysis membrane (1 mm long ϫ 0.32 mm in diameter) was inserted via the guide tube into the RVM. The 1-mm membrane portion extended beyond the end of the guide tube, so that the tip lay at or near the ventral medullary surface.
Experimental protocol. Throughout the experiment, the RVM was dialyzed at a rate of 8.5 l/min with an artificial cerebrospinal fluid (aCSF) solution equilibrated with 5% CO2 (this dialysis flow rate caused no volume transduction of fluid across the dialysis membrane). After placement of the dialysis probe, Ն60 min elapsed before any blood pressure challenges were performed. When blood pressure and ventilatory variables were stable and unchanged for Ն10 min, a small dose of sodium cyanide (0.1 mg/kg iv) was used to ensure that the carotid bodies were intact and innervated. A brief increase in peak integrated phrenic nerve amplitude and/or frequency Ͼ125% of control was taken as evidence that the carotid bodies were intact. Absence of such a response was taken as an indication of chemodenervation, and results from two piglets were excluded from analysis on this basis.
We used phenylephrine, an ␣-adrenergic-receptor agonist, to elevate systemic blood pressure and elicit baroreflex inhibition of respiration. We allowed a recovery period of Ն15 min after the sodium cyanide test before testing the baroreflex, at which time each animal's baseline responses to intravenous administration of phenylephrine were measured. The response of individual animals to phenylephrine differed; thus each animal was tested to determine the dose required to produce an increase in mean arterial blood pressure (MAP) of ϳ40-50 mmHg. MAP was calculated on-line using Chart software (PowerLab). The responses after two or three infusions of phenylephrine were recorded to determine the baseline response. Each infusion was separated by Ն5 min, during which full recovery of blood pressure and phrenic nerve activity occurred. After these control studies, the aCSF in the dialysis syringe was replaced with 10 mM muscimol in aCSF. Muscimol was dialyzed for 10 min before the muscimol was replaced with aCSF alone, and dialysis was resumed to begin a washout period. The phenylephrine challenges were repeated during the washout phase of dialysis exactly as they had been during the initial control period. The muscimol solution contained a small amount of fast green, which allowed us to estimate the time at which the muscimol solution reached the brain. Control animals were subjected to aCSF dialysis throughout the study without muscimol, and the time course of sham "before" and "after" trials remained the same as for test animals. One control animal was not subjected to dialysis, but the time course of phenylephrine challenges remained the same.
Neuroanatomy. On termination of the experiment, 20-50 l of filtered 1% aqueous KMnO 4 solution were microinjected through a dialysis probe with the tip broken back slightly to mark the site of dialysis (30) . The brain stem was removed, and the ventral surface was photographed. The permanganate was often visible on the ventral surface of the brain and easily visible when the brain was sectioned. This facilitated identification of the position of the dialysis probe tip. A photograph of the KMnO4 on the ventral surface of the brain provided a permanent record of the site of muscimol microdialysis with respect to external brain stem landmarks (see Fig. 4 ). The external landmarks were correlated with the location in computer reconstructions and further analyses of cut sections.
Immediately after removal, the brain stem was placed in cryoembedding medium (Tissue-Tek OCT 458, Sakura Finetek, Torrance, CA) and frozen in isopentane at Ϫ70°C. The brain stem was cut into 20-to 50-m sections in a cryostat at Ϫ18°C, and the sections were mounted on gelatinized glass slides. Sections were fixed in formol alcohol overnight and stained with cresyl violet (1, 21) .
The rostrocaudal dimensions of the brain stem differed significantly among piglets over the ages we studied, and coordinates expressed in millimeters relative to the bregma or interaural line did not accurately portray the location of probes with respect to ventral medullary nuclei. Therefore, we decided to express the location of each probe with respect to medullary structures, which we believe are the anatomically relevant sites. The medullary nuclei move in a predictable way relative to the external landmarks as animals age, and the dialysis probes were placed according to a regression equation using animal age and external landmarks (30) . However, the position of the dialysis probe within the brain stem was described with respect to the caudal end of the facial nucleus and the midline and ventral surface of the brain stem. The site of each dialysis probe was plotted on a grid, which represented the average ventral surface area of the facial nucleus (5) , and the location of each dialysis probe was expressed by three dimensions in millimeters: a normalized rostrocaudal dimension referenced to the caudal end of the facial nucleus, an absolute mediolateral dimension referenced to the midline, and an absolute dorsoventral dimension referenced to the ventral surface of the brain stem (5, 6) .
Data analysis and statistics. We measured the fractional end-tidal CO 2 and integrated phrenic activity. The peak phrenic activity, instantaneous respiratory frequency, and minute phrenic activity (phrenic amplitude ϫ respiratory frequency) of each breath were calculated from the integrated phrenic activity. Baseline respiratory activity was estimated from the 10 breaths preceding the phenylephrine infusion. The response to phenylephrine was determined from the relationship between peak MAP and ventilation. The peak MAP was related to the single breath that showed maximum inhibition after infusion of phenylephrine. The maximally inhibited breath was normally associated with the maximal level of blood pressure achieved and occurred within 5.8 Ϯ 0.5 s after the onset of the blood pressure increase. If the maximal respiratory response occurred before the peak blood pressure after phenylephrine injection, the average blood pressure measured during a period equal to 150% of the time of the preceding breath was calculated as the blood pressure producing the response. The blood pressure response to phenylephrine declined more quickly than the respiratory response, and the average blood pressure over the entire respiratory response would have underestimated the value of the putative baroreceptor stimulus.
Data were analyzed using a two-way repeated-measures ANOVA in which muscimol (control vs. 10 mM dialysis) and phenylephrine (control vs. infusion) were within-subject factors (Systat 9.0, SPSS Science, Chicago, IL). When the ANOVA indicated that significant differences existed among groups (the F test was significant at P Յ 0.05), we used Bonferroni's method to adjust P values for multiple preplanned comparisons.
We performed cluster analysis to determine whether we could identify neuroanatomic groupings of dialysis sites with similar respiratory responses to phenylephrine after muscimol dialysis (Systat 9.0). In the cluster analysis, we defined muscimol responsiveness as follows
where f is the respiratory frequency, cntrl is before phenylephrine infusion, PE is after phenylephrine infusion, postmusc is after muscimol dialysis, and premusc is before muscimol dialysis. In the cluster analysis, we included four variables: the percent change in respiratory frequency and the rostrocaudal, mediolateral, and dorsoventral coordinates of the dialysis probe. Cluster analysis may impose structure on data where there is none, and to avoid that, we used multiple clustering protocols and metrics within each analysis (34) . We performed a post hoc analysis on a subset of piglets selected for large responses to phenylephrine after muscimol dialysis. The magnitude of the response to muscimol was judged from the absolute change in respiratory frequency after muscimol dialysis and phenylephrine and the percent change in respiratory frequency, as defined above. We analyzed this subset of large responders using a two-way ANOVA as outlined above, but when the ANOVA indicated that significant differences existed among groups, we used Scheffé's method to keep the aggregate P Յ 0.05 for all possible comparisons within a particular analysis. Scheffé's method is the most stringent of tests used to make multiple comparisons and protects against type I errors (incorrectly rejecting the null hypothesis). Values are means Ϯ SE.
RESULTS

Effect of phenylephrine on ventilation before and after muscimol.
The response of a single piglet to phenylephrine before and after muscimol is shown in Fig. 1 . In Fig. 1A , the integrated phrenic nerve activity, the end-tidal CO 2 , and blood pressure are shown as a function of time. Phenylephrine infusion increased the blood pressure, and associated with the increase in blood pressure, the respiratory frequency slowed and the amplitude of phrenic activity declined. Respiratory activity recovered as the blood pressure returned to the Fig. 1 . Integrated phrenic nerve activity (phrenic amplitude), endtidal CO2 (ETCO 2 ), and mean arterial blood pressure (MAP) from a single piglet plotted as a function of time before (A) and after (B) muscimol dialysis. Arrows, phenylephrine infusion (0.1 g). Respiratory rate increased after muscimol dialysis, and respiratory inhibition associated with phenylephrine infusion was enhanced by muscimol dialysis. au, Arbitrary units. control level. After muscimol dialysis into the RVM at the caudal and medial aspect of the facial nucleus, the respiratory frequency increased, and the inhibition of respiration associated with phenylephrine was enhanced.
It was our original expectation that some dialysis probes would be positioned within the RVM, but inevitably some would be placed outside the RVM. Those animals with probes outside the RVM were to provide a control group. These expectations were unfulfilled for two reasons. First, we placed the probes within the RVM more effectively than in previous studies, and as described below, we found no evidence that responses to phenylephrine differed as a function of anatomy within the RVM. Second, the RVM was defined by effects on CO 2 chemosensitivity (5, 6), and we had no a priori reason to believe that the anatomic regions sustaining respiratory activity after phenylephrine infusion were identical to the CO 2 chemosensory areas in the RVM. Therefore, we pooled all the muscimol dialysis sites as a first analysis to determine whether muscimol dialysis anywhere in the region we tested altered the response to phenylephrine.
The average responses of MAP, respiratory frequency, peak integrated phrenic amplitude, and minute phrenic activity from all muscimol dialysis experiments are plotted before and after phenylephrine and before and after muscimol dialysis. The blood pressure rose significantly after phenylephrine (P Յ 0.0001). The level of MAP at baseline and after phenylephrine was ϳ5 mmHg less after muscimol than during the control period (P ϭ 0.003). However, the change in MAP after phenylephrine was similar before and after muscimol dialysis. The average end-tidal PCO 2 was 38 Torr, and there was no change in end-tidal PCO 2 among the control and test conditions (data not shown). We did occasionally observe a transient fall in end-tidal PCO 2 during the phenylephrine-induced episodes of hypertension. We attributed this to an acute decline in cardiac output and decreased delivery of CO 2 to the lungs. The fall in end-tidal PCO 2 was transient, not statistically significant, and appeared to follow, rather than cause, the episodes of respiratory inhibition.
Baroreceptor stimulation by phenylephrine infusion inhibited respiratory activity in the control period (Fig.  2) . Respiratory frequency fell consistently after phenylephrine infusion (P Ͻ 0.001), and phenylephrine treatment reduced the peak integrated phrenic amplitude (P Ͻ 0.001). Finally, phenylephrine infusion decreased minute phrenic activity significantly (P Ͻ 0.001).
Muscimol dialysis into the RVM amplified the inhibitory effect of phenylephrine that was present during the control period. The fall in frequency after phenylephrine treatment was significant after muscimol dialysis (P Ͻ 0.0001), and the fall in frequency after muscimol dialysis was significantly greater than the decline in frequency in the control condition (P Ͻ 0.004). There was also a significant increase in respiratory frequency in the prephenylephrine control period after muscimol dialysis compared with the control period before muscimol dialysis (P Ͻ 0.001). There is an inverse relationship between respiratory frequency and carotid sinus pressure in the steady state in anesthetized dogs (2), and we wondered if the fall in MAP after muscimol dialysis was associated with the increased respiratory frequency after muscimol. However, there was no correlation between the change in MAP in the control periods before phenylephrine was given before and after muscimol dialysis and the change in respiratory frequency measured during the same periods (Pearson correlation coefficient ϭ 0.26, P Ͼ 0.1).
Phenylephrine treatment reduced the peak integrated phrenic amplitude after muscimol treatment Fig. 2 . Average MAP (A), respiratory frequency (B; in breaths/min), peak integrated phrenic activity (C), and minute phrenic activity (D) from all piglets studied with muscimol dialysis plotted as a function of test condition. Muscimol dialysis significantly enhanced respiratory inhibition of respiratory frequency and minute phrenic activity associated with phenylephrine infusion. ** Significant main effect of phenylephrine, P Յ 0.05.
ϩϩ Significant main effect of muscimol, P Յ 0.05. * Significant difference between phenylephrine control and test conditions within muscimol control or test condition, P Յ 0.05. ϩ Significant difference between control conditions before phenylephrine was given, P Յ 0.05. # Phenylephrine effect, although significant before and after muscimol dialysis, was significantly enhanced after muscimol dialysis, P Յ 0.05.
(P Ͻ 0.001). However, the size of the reduction in phrenic amplitude after phenylephrine treatment was similar before and after muscimol dialysis. Moreover, muscimol significantly decreased phrenic activity before and after phenylephrine infusion compared with control values (P ϭ 0.027). After muscimol treatment, the control values of frequency before phenylephrine rose, but phrenic amplitude fell. As a result, minute phrenic activity before phenylephrine treatment was not different before and after muscimol dialysis. However, the phenylephrine infusion decreased minute activity significantly after muscimol treatment (P Ͻ 0.001), and the reduction in minute activity caused by phenylephrine was significantly greater after muscimol than the control value (P ϭ 0.028).
Significant developmental changes occur in piglets over the ages we studied, and we examined the effect of piglet age on the responses to muscimol dialysis and phenylephrine administration by correlating the percent change in respiratory frequency after muscimol dialysis with piglet age in days. There was no correlation (P ϭ 0.65); thus piglet age was not related to the size of the muscimol effect over the range of piglet ages that we studied.
Time control for muscimol dialysis. Muscimol has a long half-life binding to the GABA A receptor. Therefore, muscimol dialysis always followed the control study period, and muscimol treatment might have been confounded by a time effect or by the duration of dialysis with aCSF. To examine the contribution of time alone to the "muscimol" effect, we performed control studies in six piglets. In five piglets, we continuously dialyzed the RVM with aCSF and studied the phenylephrine response during control and test periods that matched the times of the control and muscimol tests described above. The dialysis probes in these control animals were within the same ventral medullary region as the actual muscimol dialysis experiments (see Fig. 5 ). In the remaining piglet, we did not place a dialysis probe but followed the temporal sequence of the muscimol experiments in all other respects. The average responses of MAP, respiratory frequency, peak integrated phrenic amplitude, and minute phrenic activity from these studies are shown in Fig. 3 . Baseline values of MAP, respiratory frequency, phrenic amplitude, and minute phrenic activity before phenylephrine administration were stable over the course of the experiment. Phenylephrine increased MAP (P ϭ 0.001) and reduced respiratory frequency (P ϭ 0.007) and minute phrenic activity (P ϭ 0.007). The effects of phenylephrine on these variables were similar in the first and second time periods. The phrenic amplitude was similar among all conditions tested. Thus neither time alone nor prolonged dialysis can account for the enhanced respiratory inhibition caused by phenylephrine infusion after muscimol dialysis.
Anatomic location of dialysis probes. An example of the location of a dialysis probe is shown in a cross section of the medulla in Fig. 4 . The locations of the dialysis probes in the muscimol and control experiments are shown schematically in Fig. 5 . The probes were placed over the superficial aspect of the RVM. The region affected by the probes extended rostrally 5.22 mm from the caudal pole of the facial nucleus and Ϫ0.57 mm caudally from the end of the facial nucleus. It extended 0.90-4.88 mm medially from the midline and was 0.00-2.47 mm deep from the ventral surface. Within this volume, probes were placed homogenously with respect to the rostrocaudal and mediolateral dimensions. Among the probes placed for muscimol dialysis experiments, two probes were Ͼ1.2 mm deep to the ventral surface, but the remaining 23 probes were located superficially within 1.2 mm of the ventral surface.
Variable responses to phenylephrine among piglets. We noted considerable variability among responses in different piglets. We investigated this variability in two ways: we analyzed the relationship of the magnitude of the response to phenylephrine infusion as a function of the neuroanatomic location of the dialysis probe, and we examined the character of the responses of the subset of piglets with large responses to phenylephrine.
Response magnitude and dialysis location within the RVM. The RVM was defined previously by the effect of muscimol dialysis on ventilatory responses to CO 2 (5, 6) . Because we did not analyze the ventilatory response to hypercapnia in this study, we used cluster analysis based on anatomy and responses to phenylephrine and muscimol to determine whether small regions within the area we tested were associated with greater inhibition of respiratory frequency after phenylephrine infusions. Cluster analysis is an empirical statistical approach, and quite different results may be obtained with modest changes in model conditions. Therefore, we used a hierarchical protocol with complete linkage and the K-means routine to obtain clusters, and we used a variety of metrics. We were looking for responders vs. nonresponders to muscimol, so we arbitrarily examined only the two cluster solutions. These multiple methods and conditions resulted in remarkably similar results. The results of the K-means cluster protocol using complete linkage are shown in Table 1 . The results indicate that different clusters do exist on the basis of rostrocaudal coordinates. However, these clusters do not differ with respect to the other two dimensions or percent change in frequency. The clustering simply identified a rostral and a caudal grouping of probe locations without respect to muscimol responsiveness. We confirmed this by performing an ANOVA on the RVM groups identified by cluster analysis, and muscimol dialysis enhanced the inhibitory effect of phenylephrine on respiratory frequency similarly in both clusters. Hence, there was no evidence that specific regions within the RVM, defined anatomically or empirically, differed with respect to the capacity of muscimol to enhance respiratory inhibition after phenylephrine infusion.
Analysis of the subset of large responders. Although we could not identify any anatomic criterion to select the most responsive animals, inspection of the responses of individual piglets suggested that the piglets fell into two groups: responders and nonresponders. Therefore, we examined the average results of animals with large responses to phenylephrine after muscimol dialysis. An example of the profound enhancement of respiratory inhibition that we observed in some piglets is shown in Fig. 6 . We selected a group of piglets with large responses by identifying animals in which muscimol dialysis enhanced the response of respiratory frequency to phenylephrine by Ͼ50% and in which the absolute change in respiratory frequency during phenylephrine infusion after muscimol dialysis was Ͼ5 breaths/min. In two piglets with large responses as defined above, respiratory frequency actually rose when phenylephrine was given after muscimol dialysis, but we also identified nine piglets in which enhancement of the inhibitory effect of muscimol was large. The anatomic locations of the dialysis probes in these groups were not remarkable; the probe locations were distributed throughout the RVM with no evidence of anatomic clustering. The average responses of these nine piglets with large responses are presented in Fig.  7 . The responses of these animals contributed significantly to the results we observed for the entire group, since there was no significant effect of muscimol dialysis on the phenylephrine response if we analyzed the responses of the remaining piglets (including the two piglets with "paradoxical" phenylephrine responses after muscimol dialysis). Although this is a post hoc analysis, closer inspection of results from the large responders may provide some insight into the mechanism of the responses to muscimol. The blood pressure stimulus was similar before and after muscimol dialysis in these animals, and the phenylephrine treatment increased blood pressure significantly (P Ͻ 0.001; all P values were adjusted using Scheffé's method for these post hoc comparisons). The respiratory frequency rose significantly after muscimol and before phenylephrine treatment (P Ͻ 0.05), and phenylephrine treatment slowed the respiratory frequency (P Ͻ 0.05). The frequency drop after phenylephrine was significantly enhanced by muscimol (P Ͻ 0.001). Muscimol decreased phrenic amplitude (P ϭ 0.02), but the decrease in phrenic amplitude after phenylephrine was not significant (P ϭ 0.25), and there was no effect of the combination of phenylephrine and muscimol on phrenic amplitude. Phrenic minute activity fell significantly after muscimol dialysis before administration of phenylephrine (P Ͻ 0.05). The inhibition of minute activity after phenylephrine administration was greater after muscimol dialysis (P ϭ 0.05). The foregoing results differ from the average responses of the entire group of 25 piglets: there was greater inhibition of respiratory frequency and minute activity by muscimol dialysis even before phenylephrine was infused, and phenylephrine had no effect on phrenic amplitude. The effect of phenylephrine on respiratory frequency was also larger before and after muscimol dialysis in these animals (as it must have been on the basis of our selection criteria).
DISCUSSION
The main finding of this study is that muscimol dialysis in the RVM substantially accentuated the ventilatory depression associated with an acute elevation of blood pressure in the decerebrate piglet. The effect of muscimol dialysis on the response to phenylephrine was variable among piglets. The responses of nine piglets were large and accounted almost completely for the average responses of the entire group. The dialysis probe locations in the piglets with large responses were spread throughout the RVM and not clearly different from the nonresponders.
Muscimol effects on ventilation before phenylephrine infusion. The values of respiratory frequency and the pattern of peak phrenic amplitude and minute phrenic activity are similar to those previously reported in decerebrate piglets (5) . Minute phrenic activity was stable in the control period preceding phenylephrine infusion before and after muscimol dialysis. However, the respiratory frequency rose significantly, and phrenic amplitude fell. The changes in respiratory frequency and minute activity after muscimol dialysis were even greater in the group of large responders (Fig.  7) . The large responders were selected on the basis of the response to phenylephrine, but the group also had large responses to muscimol alone before phenylephrine was administered. Thus muscimol altered the respiratory pattern and reduced respiratory drive even before phenylephrine was given. The fall in amplitude and the rise in frequency probably reflect a single process, since there tends to be a reciprocal relationship between phrenic amplitude and frequency even in vagotomized decerebrate animals when respiratory drive changes (5, 10). Dreshaj et al. (10) noted a similar change in respiratory frequency after inhibition in the raphé, another CO 2 -sensitive region within the medulla, with lidocaine or ibotenic acid. The dialysis probe not only added muscimol to the RVM (when muscimol was added to the dialysate), but dialysis also takes substances up from the CNS into the dialysate. Dialysis with aCSF alone might have had a modest inhibitory effect by reducing neurotransmitter concentrations in the region of the probe over time. Moreover, simply placing the probe may also disrupt the function of the region. However, the effects of muscimol dialysis are unlikely to be attributed to placement of the probe or prolonged dialysis, since there were no time-dependent changes in respiratory frequency, peak integrated phrenic activity, or minute phrenic activity in the control studies we conducted or in the control periods before and after muscimol dialysis in our previous study using a protocol with longer dialysis periods (5).
Muscimol effects on phenylephrine-induced respiratory inhibition. Phenylephrine raises the blood pressure and stimulates baroreceptors, and baroreceptor stimulation inhibits respiratory activity (18) . Muscimol dialysis enhanced the respiratory inhibition associated with phenylephrine infusion in the piglets we studied. Muscimol is a GABA A agonist with high affinity for the GABA receptor, and GABA receptors are ubiquitous. We believe that muscimol inhibits neurons in the RVM and reduces the excitatory drive to breathe. As a result, respiratory inhibition after phenylephrine was more profound after muscimol dialysis. Thus a facilitatory drive, originating in the RVM, stabilizes the respiratory output in the presence of inhibitory stimuli. However, we do not believe that the excitation arising within the RVM is specific for baroreceptor inhibition of respiration, since manifestations of the laryngeal chemoreflex, which is associated with Fig. 6 . Integrated phrenic nerve activity (phrenic amplitude), endtidal CO2, and blood pressure (BP) from 1 piglet plotted as a function of time before (A) and after (B) muscimol dialysis. Note profound respiratory inhibition associated with phenylephrine infusion after muscimol dialysis. In this animal, respiratory frequency fell after muscimol dialysis into the RVM, but in all other piglets with large responses to phenylephrine, respiratory frequency did not change or increased after muscimol dialysis. Fig. 7 . Average MAP (A), respiratory frequency (B), peak integrated phrenic activity (C), and minute phrenic activity (D) from 9 piglets with large responses to phenylephrine after muscimol dialysis plotted as a function of test condition. Muscimol dialysis significantly enhanced inhibition of respiratory frequency and minute phrenic activity associated with phenylephrine infusion, and muscimol alone significantly increased respiratory frequency and reduced minute phrenic activity. See Fig. 2 legend for explanation of symbols. respiratory inhibition, are also enhanced in intact sleeping piglets after muscimol dialysis in the RVM (32) .
The enhanced inhibitory effect of phenylephrine infusion after muscimol was manifest only on frequency. Phrenic amplitude was reduced by phenylephrine infusion and by muscimol dialysis, but there was no interaction between the two treatments, and the reduction in phrenic amplitude was similar before and after muscimol dialysis. The effect on frequency also seems to be specific for the interaction between phenylephrine and muscimol, since the effect of muscimol dialysis on the CO 2 response of decerebrate piglets was mediated exclusively through an effect on tidal volume (5) .
Muscimol responsiveness to phenylephrine: relationship to CO 2 chemosensitivity. We did not test the ventilatory response to CO 2 in this study, but in our previous studies, muscimol dialysis in the RVM reduced the ventilatory response to CO 2 (5, 6) . CO 2 chemosensitivity seems to be present homogeneously within the RVM; we have not seen such clear distinctions between nonresponders and responders when examining the effect of muscimol dialysis on ventilatory responses to CO 2 (5, 6) . The heterogeneity of the phenylephrine responses to muscimol dialysis suggests that the RVM may contain small clusters of neurons involved in cardiorespiratory control. These neurons may be CO 2 sensitive, but additional regions within the RVM are probably CO 2 sensitive but not involved in cardiorespiratory interactions. On the other hand, muscimol may also act by CO 2 -independent mechanisms. In a series of studies of awake and anesthetized goats, Forster et al. (14) and Ohtake et al. (24) used cooling thermodes placed bilaterally on the ventrolateral surface of the medulla to inhibit neural activity. Brief cooling of the ventral surface inhibited respiration equally during hypoxia, hypercapnia, and exercise: there was no specific effect of cooling on the hypercapnic ventilatory response. When the duration of cooling was prolonged, which increased the depth of neural inhibition into the ventral medulla, the respiratory inhibition was greater during hypercapnia. Similar results were obtained in neonatal goats (26) . These data are consistent with the hypothesis that a tonic, CO 2 -insensitive, facilitatory input to respiratory activity originates in the superficial RVM. Muscimol dialysis in the RVM may have reduced this tonic facilitatory input and enhanced the respiratory inhibition associated with phenylephrine infusion. One might have expected evidence of respiratory inhibition after muscimol dialysis alone if this were the case. For example, bilateral cooling of the ventral surface caused apnea in anesthetized goats (24) . However, we saw no inhibition of ventilatory output after muscimol dialysis until phenylephrine was administered when the entire group of animals treated by muscimol dialysis was analyzed. It may be pertinent that our dialysis probes were placed unilaterally, and the region affected by the dialysate was only a small fraction of the total volume of the RVM (bilateral inhibition of the RVM with muscimol does cause apnea in decerebrate piglets; unpublished observations). Furthermore, there was inhibition of ventilatory activity after muscimol dialysis in the animals with larger responses to phenylephrine before phenylephrine was given (Fig. 7) . The reduction in ventilatory activity after muscimol dialysis in this group of large responders is consistent with loss of a facilitatory input from the RVM, but our data do not directly address the contribution of CO 2 chemosensory mechanisms to this facilitatory drive to ventilation.
There is one hint in our data that the baroreflexmediated inhibition of respiration does not involve a CO 2 chemosensory mechanism. Muscimol dialysis in the RVM reduced the ventilatory response to CO 2 by reducing the tidal volume (6) . We observed a fall in phrenic amplitude after muscimol dialysis before phenylephrine was administered. However, among the large responders, the interactive effect of phenylephrine and muscimol was solely manifest as a drop in respiratory frequency (Fig. 7) ; there was no effect of phenylephrine on phrenic amplitude alone or in combination with muscimol. This suggests that the phenylephrine effect was independent of factors controlling phrenic amplitude and tidal volume and, therefore, independent of CO 2 chemosensory mechanisms in the RVM, since these seem to operate in neonatal piglets by affecting phrenic amplitude and tidal volume.
Site of cardiorespiratory interactions. The neural substrate of phenylephrine-induced respiratory inhibition within the CNS is incompletely characterized. With respect to cardiovascular control, baroreceptor afferents arrive in the nucleus tractus solitarius, and the inhibition of sympathetic vasomotor tone and activation of vagal efferents are mediated by the CVLM and RVLM and cardiovagal motoneurons in the nucleus ambiguus, respectively (16, 31) . We believe that the RVLM identified by Guyenet and others (15, 16 ) is caudal and slightly dorsal to the RVM, as we have defined it. However, the rostral RVLM and the caudal RVM may well overlap each other. Kynurenic acid uncoupled sympathorespiratory interactions when injected into the RVM (15). Guyenet et al. actually called the region affected by these injections the RVLM, but the injections that modified cardiorespiratory interactions were rostral to the caudal pole of the facial nucleus in the region we defined as the RVM (see Fig. 6 in Ref. 15) , and similar effects on cardiorespiratory interactions were not seen after injections made caudal to the facial nucleus. Thus we believe that the RVM may play an important role specifically in cardiorespiratory interactions.
A circuit for respiratory inhibition by baroreceptor activation mediated through the RVM has not been described, but two possibilities occur to us. First, efferent projections from the nucleus tractus solitarius that are activated by baroreceptor stimulation may inhibit the central pattern generator within the dorsal and ventral respiratory groups. In this scheme, the effect of muscimol dialysis in the RVM would be mediated by withdrawal of a facilitatory input to the central pattern generator. This places the site of integration of cardiorespiratory interactions in the respiratory central pattern generator. Alternatively, inhibitory activity de-rived from baroreceptor stimulation might directly inhibit the neurons within the RVM that provide a facilitatory input to respiration. Baroreceptor information could even arrive at the RVM through the closely adjacent RVLM (16) . This places the site of integration of cardiorespiratory interactions in the RVM. In favor of the latter hypothesis, Harper et al. (17) found that phenylephrine-induced respiratory depression was associated with marked diminution of neural activity on the surface of the RVM. If the RVM has an integrative function, this activity may be shared with other sites, since activation of the CVLM, for example, also modifies cardiorespiratory interactions (31) .
Implications for SIDS. The triple-risk model for the pathogenesis of SIDS suggests that three factors contribute to the death of each infant: an underlying vulnerability, a critical period of homeostatic control, and an exogenous stressor (13) . We studied an exogenous stressor that inhibits ventilation (phenylephrine) in a neonatal piglet with an experimentally induced vulnerability (inhibition of the RVM by muscimol dialysis). The results of the study are consistent with the triple-risk model of SIDS, in that inhibition of the RVM enhanced the inhibition of respiration associated with phenylephrine infusion and destabilized the respiratory output. One may reasonably ask whether either of our experimental interventions is relevant to SIDS. We believe that they are. Sleep in neonates is punctuated by multiple arousals, many of which have a stereotypical pattern of startle, hypertension and tachycardia, apnea, and arousal (20, 23) . We found a similar pattern of hypertension and tachycardia followed by apnea in neonatal piglets (3) . Hence, hypertension as part of an arousal may precipitate an apnea. It is our hypothesis that loss of input from the RVM might prolong the apnea and increase respiratory instability associated with the arousal. Regardless of the plausibility of hypertension and respiratory inhibition as triggers in the pathogenesis of SIDS, the results of the present study provide evidence that neurons within the RVM sustain and stabilize respiratory activity. The effects of muscimol are also consistent with current hypotheses about the underlying vulnerability associated with SIDS. GABA receptors are ubiquitous, and muscimol dialysis mimics to some extent the loss of neurons observed in the arcuate nucleus in some babies who died of SIDS (12, 22) . On the other hand, infants who died of SIDS have reduced muscarinic, kainate, and serotonergicreceptor binding within multiple regions of the brain stem (19, 27, 28) , and the effect of muscimol is not specific for any of the actual neurotransmitter defects identified thus far in SIDS victims.
In summary, we have demonstrated that muscimol dialysis in an extended region of the RVM enhances respiratory inhibition after phenylephrine infusion in decerebrate neonatal piglets. Thus the loss of a facilitatory input to respiratory drive, which originates in the RVM and may or may not be related to CO 2 sensitivity within the RVM, promoted respiratory instability in these animals.
